Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21114475rdf:typepubmed:Citationlld:pubmed
pubmed-article:21114475lifeskim:mentionsumls-concept:C0015031lld:lifeskim
pubmed-article:21114475lifeskim:mentionsumls-concept:C0007226lld:lifeskim
pubmed-article:21114475lifeskim:mentionsumls-concept:C0033487lld:lifeskim
pubmed-article:21114475lifeskim:mentionsumls-concept:C1521970lld:lifeskim
pubmed-article:21114475lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:21114475lifeskim:mentionsumls-concept:C0020591lld:lifeskim
pubmed-article:21114475lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:21114475pubmed:issue1lld:pubmed
pubmed-article:21114475pubmed:dateCreated2011-1-4lld:pubmed
pubmed-article:21114475pubmed:abstractTextWe compared the propofol dose causing loss of verbal response and suppression of bispectral index to 50, between 50 white and 50 black patients, aged 18-65 years. Propofol was administered at 40 mg.kg?¹.h?¹ and reduced to 8 mg.kg?¹.h?¹ when bispectral index fell to 50. We recorded heart rate and mean arterial pressure for 15 min in total and calculated, for this period, maximal percentage change from baseline for each. A statistician, blinded to patient ethnicity, found mean (SD) propofol dose for loss of verbal response in white and black patients to be 1.41 (0.37) mg.kg?¹ and 1.16 (0.25) mg.kg?¹, respectively (p < 0.001). Corresponding figures for maximal percentage change in heart rate were 14.1 (12.6) % and 7.5 (14.0) % (p = 0.015). Other differences were non-significant. The dose of propofol required for loss of verbal response, but not for suppression of bispectral index to 50, is lower in black than in white patients.lld:pubmed
pubmed-article:21114475pubmed:languageenglld:pubmed
pubmed-article:21114475pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21114475pubmed:citationSubsetAIMlld:pubmed
pubmed-article:21114475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21114475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21114475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21114475pubmed:statusMEDLINElld:pubmed
pubmed-article:21114475pubmed:monthJanlld:pubmed
pubmed-article:21114475pubmed:issn1365-2044lld:pubmed
pubmed-article:21114475pubmed:authorpubmed-author:LewisC MCMlld:pubmed
pubmed-article:21114475pubmed:authorpubmed-author:MorleyA PAPlld:pubmed
pubmed-article:21114475pubmed:authorpubmed-author:NatarajanAAlld:pubmed
pubmed-article:21114475pubmed:authorpubmed-author:StrandvikG...lld:pubmed
pubmed-article:21114475pubmed:authorpubmed-author:ChakithandySSlld:pubmed
pubmed-article:21114475pubmed:authorpubmed-author:PattanayakRRlld:pubmed
pubmed-article:21114475pubmed:authorpubmed-author:PassalacquaA...lld:pubmed
pubmed-article:21114475pubmed:copyrightInfo© 2010 The Authors. Anaesthesia © 2010 The Association of Anaesthetists of Great Britain and Ireland.lld:pubmed
pubmed-article:21114475pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21114475pubmed:volume66lld:pubmed
pubmed-article:21114475pubmed:ownerNLMlld:pubmed
pubmed-article:21114475pubmed:authorsCompleteYlld:pubmed
pubmed-article:21114475pubmed:pagination15-9lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:meshHeadingpubmed-meshheading:21114475...lld:pubmed
pubmed-article:21114475pubmed:year2011lld:pubmed
pubmed-article:21114475pubmed:articleTitleEffect of ethnicity on the hypnotic and cardiovascular characteristics of propofol induction.lld:pubmed
pubmed-article:21114475pubmed:affiliationGuy's and St Thomas' NHS Foundation Trust, London, UK.lld:pubmed
pubmed-article:21114475pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21114475pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed